Photodynamic therapy in dermatology

European Journal of Dermatology

Volumn 16, Issue 4, 2006, Pages 340-348

  Babilas, Philipp ^a   Landthaler, Michael ^a   Szeimies, Rolf Markus ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Aminolevulinic acid; Inflammatory dermatoses; Methyl aminolevulinate; Photodynamic therapy; Skin cancer

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; PHOTOFRIN; PHOTOSENSITIZING AGENT;

ACNE VULGARIS; ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BOWEN DISEASE; CARCINOMA IN SITU; CONDYLOMA; DRUG MECHANISM; HUMAN; LICHEN SCLEROSUS ET ATROPHICUS; MORPHEA; PHOTODYNAMIC THERAPY; PSORIASIS VULGARIS; REVIEW; SQUAMOUS CELL CARCINOMA; VERRUCA VULGARIS;

CARCINOMA, BASAL CELL; HUMANS; PHOTOCHEMOTHERAPY; SKIN DISEASES; SKIN NEOPLASMS;

EID: 33748314437     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Raab O. Wirkung fluorescierender. Stoffe auf Infusorien, 1900.
2. Szeimies RM, Dräger J, Abels C, et al. History of photodynamic therapy in dermatology. In: Calzavara-Pinton PG, Szeimies RM, Ortel B, eds. Photodynamic therapy and Fluorescence Diagnosis in Dermatology. Amsterdam: Elsevier, 2001: 3-16.
3. Dougherty TJ, Grindey GB, Fiel R, et al. Photoradiation therapy. II Cure of animal tumors with hematoporphyrin and light. J Natl Cancer Inst 1975; 55: 115-21.
4. Dougherty TJ, Kaufman JE, Goldfarb A, et al. Photoradiation therapy for the treatment of malignant tumors. Cancer Res 1978; 38: 2628-35.
5. Zeitouni NC, Oseroff AR, Shieh S. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Mol Immunol 2003; 39: 1133-6.
6. Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 2004; 30: 264-71.
7. Braathen LR. Photodynamic therapy. Tidsskr Nor Laegeforen 2001; 121: 2635-6.
8. Dragieva G, Hafner J, Dummer R, et al. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation 2004; 77: 115-21.
9. Dragieva G, Prinz BM, Hafner J, et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolae-vulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 2004; 151: 196-200.
10. Morton CA. Photodynamic therapy for nonmelanoma skin cancer-and more? Arch Dermatol 2004; 140: 116-20.
11. Schweitzer VG. PHOTOFRIN-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies. Lasers Surg Med 2001; 29: 305-13.
12. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990; 6: 143-8.
13. Szeimies RM, Karrer S, Abels C, et al. Photodynamic therapy in dermatology. In: Krutmann J, Hönigsmann H, Elmets CA, Bergstresser PR, eds. Dermatological phototherapy and photodiagnostic methods. Berlin: Springer, 2001: 209-47.
14. Baas P, Saarnak AE, Oppelaar H, et al. Photodynamic therapy with meta-tetrahydroxyphenylchlorin for basal cell carcinoma: a phase I/II study. Br J Dermatol 2001; 145: 75-8.
15. Lui H, Hobbs L, Tope WD, et al. Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes. Arch Dermatol 2004; 140: 26-32.
16. Szeimies RM, Abels C, Fritsch C, et al. Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo. J Invest Dermatol 1995; 105: 672-7.
17. Brown SB. The role of light in the treatment of non-melanoma skin cancer using methyl aminolevulinate. J Dermatolog Treat 2003; 14(Suppl3): 11-4.
18. Piacquadio DJ, Chen DM, Farber HF, et al. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Arch Dermatol 2004; 140: 41-6.
19. Morton CA, Whitehurst C, Moore JV, et al. Comparison of red and green light in the treatment of Bowen's disease by photodynamic therapy. Br J Dermatol 2000; 143: 767-72.
20. Morton CA, Brown SB, Collins S, et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. Br J Dermatol 2002; 146: 552-67.
21. Haller JC, Cairnduff F, Slack G, et al. Routine double treatments of superficial basal cell carcinomas using aminolaevulinic acid-based photodynamic therapy. Br J Dermatol 2000; 143: 1270-5.
22. Soler AM, Warloe T, Berner A, et al. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 2001; 145: 467-71.
23. Thissen MR, Schroeter CA, Neumann HA. Photodynamic therapy with delta-aminolaevulinic acid for nodular basal cell carcinomas using a prior debulking technique. Br J Dermatol 2000; 142: 338-9.
24. Juzeniene A, Juzenas P, Ma LW, et al. Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy. Lasers Med Sci 2004; 19: 139-49.
25. Brancaleon L, Moseley H. Laser and non-laser light sources for photodynamic therapy. Lasers Med Sci 2002; 17: 173-86.
26. Karrer S, Baumler W, Abels C, et al. Long-pulse dye laser for photodynamic therapy: investigations in vitro and in vivo. Lasers Surg Med 1999; 25: 51-9.
27. Szeimies RM, Hein R, Baumler W, et al. A possible new incoherent lamp for photodynamic treatment of superficial skin lesions. Acta Derm Venereol 1994; 74: 117-9.
28. Alexiades-Armenakas MR, Geronemus RG. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol 2003; 139: 1313-20.
29. Soler AM, Angell-Petersen E, Warloe T, et al. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two liqht sources. Photochem Photobiol 2000; 71: 724-9.
30. Clark C, Bryden A, Dawe R, et al. Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 2003; 19: 134-41.
31. Varma S, Wilson H, Kurwa HA, et al. Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol 2001; 144: 567-74.
32. Yang CH, Lee JC, Chen CH, et al. Photodynamic therapy for bowenoid papulosis using a novel incoherent light-emitting diode device. Br J Dermatol 2003; 149: 1297-9.
33. Morton CA. Methyl aminolevulinate (Metvix) photodynamic therapy - practical pearls. J Dermatolog Treat 2003; 14(Suppl 3): 23-6.
34. Bissonnette R, Bergeron A, Liu Y. Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond. J Drugs Dermatol 2004; 3: S26-S31.
35. Stender IM, Bech-Thomsen N, Poulsen T, et al. Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice. Photochem Photobiol 1997; 66: 493-6.
36. Moore JV, Allan E. Pulsed ultrasound measurements of depth and regression of basal cell carcinomas after photodynamic therapy: relationship to probability of 1-year local control. Br J Dermatol 2003; 149: 1035-40.
37. Szeimies RM, Karrer S, Radakovic-Fijan S, et al. Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. J Am Acad Dermatol 2002; 47: 258-62.
38. Foley P. Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy. J Dermatolog Treat 2003; 14(Suppl 3): 15-22.
39. Touma D, Yaar M, Whitehead S, et al. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 2004; 140: 33-40.
40. Pagliaro J, Elliott T, Bulsara M, King C, Vinciullo C. Cold air analgesia in photodynamic therapy of basal cell carcinomas and Bowen's disease: an effective addition to treatment: a pilot study. Dermatol Surg 2004; 30: 63-6.
41. Wulf HC, Philipsen P. Allergic contact dermatitis to 5-aminolaevulinic acid methylester but not to 5-aminolaevulinic acid after photodynamic therapy. Br J Dermatol 2004; 150: 143-5.
42. Guillen C, Sanmartin O, Escudero A, et al. Photodynamic therapy for in situ squamous cell carcinoma on chronic radiation dermatitis after photosensitization with 5-aminolaevulinic acid. J Eur Acad Dermatol Venereol 2000; 14: 298-300.
43. Babilas P, Landthaler M, Szeimies RM. Actinic keratoses. Hautarzt 2003; 54(6): 551-60.
44. Sidoroff A. Actinic keratosis. In: Calzavara-Pinton PG, Szeimies RM, Ortel B, eds. Photodynamic therapy and Fluorescence Diagnosis in Dermatology. Amsterdam: Elsevier, 2001: 199-216.
45. Freeman M, Vinciullo C, Francis D, et al. A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 2003; 14: 99-106.
46. Pariser DM, Lowe NJ, Stewart DM, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003; 48: 227-32.
47. Morton CA, Whitehurst C, McColl JH, et al. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol 2001; 137: 319-24.
48. Salim A, Leman JA, McColl JH, et al. Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 2003; 148: 539-43.
49. Horn M, Wolf P, Wulf HC, et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003; 149: 1242-9.
50. Rhodes LE, de Rie M, Enstrom Y, et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004; 140: 17-23.
51. Wang I, Bendsoe N, Klinteberg CA, et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001; 144: 832-40.
52. Kuijpers DI, Smeets NW, Krekels GA, et al. Photodynamic therapy as adjuvant treatment of extensive basal cell carcinoma treated with Mohs micrographic surgery. Dermatol Surg 2004; 30: 794-8.
53. Karrer S, Abels C, Landthaler M, et al. Topical photodynamic therapy for localized scleroderma. Acta Derm Venereol 2000; 80: 20-7.
54. Itoh Y, Ninomiya Y, Tajima S, et al. Photodynamic therapy of acne vulgaris with topical delta-aminolaevulinic acid and incoherent light in Japanese patients. Br J Dermatol 2001; 144: 575-9.
55. Stender IM, Na R, Fogh H, et al. Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet 2000; 355: 963-6.
56. Ibbotson SH. Topical 5-aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non-melanoma skin cancer. Br J Dermatol 2002; 146: 178-88.
57. Bissonnefte R, Zeng H, McLean DI, et al. Oral aminolevulinic acid induces protoporphyrin IX fluorescence in psoriatic plaques and peripheral blood cells. Photochem Photobiol 2001; 74: 339-45.
58. Stringer MR, Collins P, Robinson DJ, et al. The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. J Invest Dermatol 1996; 107: 76-81.
59. Boehncke WH, Sterry W, Kaufmann R. Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 1994; 343: 801.
60. Collins P, Robinson DJ, Stringer MR, et al. The variable response of plaque psoriasis after a single treatment with topical 5-aminolaevulinic acid photodynamic therapy. Br J Dermatol 1997; 137: 743-9.
61. Robinson DJ, Collins P, Stringer MR, et al. Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta Derm Venereol 1999; 79: 451-5.
62. Beattie PE, Dawe RS, Ferguson J, et al. Lack of efficacy and tolerability of topical PDT for psoriasis in comparison with narrow-band UVB phototherapy. Clin Exp Dermatol 2004; 29: 560-2.
63. Radakovic-Fijan S, Blecha-Thalhammer U, Schleyer V, et al. Topical aminolaevulinic acid-based photodynamic therapy as a treatment option for psoriasis? Results of a randomized, observer-blinded study. Br J Dermatol 2005; 152: 279-83.
64. Stender IM, Wulf HC. Kobner reaction induced by photodynamic therapy using delta-aminolevulinic acid. A case report. Acta Derm Venereol 1996; 76: 392-3.
65. Brentjens MH, Yeung-Yue KA, Lee PC, et al. Human papilloma-virus: a review. Dermatol Clin 2002; 20: 315-31.
66. Fehr MK, Chapman CF, Krasieva T, et al. Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid. Am J Obstet Gynecol 1996; 174: 951-7.
67. Ross EV, Romero R, Kollias N, et al. Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5-aminolaevulinic acid: implications for photodynamic treatment. Br J Dermatol 1997; 137: 736-42.
68. Smetana Z, Malik Z, Orenstein A, et al. Treatment of viral infections with 5-aminolevulinic acid and light. Lasers Surg Med 1997; 21: 351-8.
69. Ammann R, Hunziker T, Braathen LR. Topical photodynamic therapy in verrucae. A pilot study. Dermatology 1995; 191: 346-7.
70. Slender IM, Lock-Andersen J, Wulf HC. Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolaevulinic acid: a pilot study. Clin Exp Dermatol 1999; 24: 154-9.
71. Fabbrocini G, Di Costanzo MP, Riccardo AM, et al. Photodynamic therapy with topical delta-aminolaevulinic acid for the treatment of plantar warts. J Photochem Photobiol B 2001; 61: 30-4.
72. Frank RG, Bos JD. Photodynamic therapy for condylomata acuminata with local application of 5-aminolevulinic acid. Genitourin Med 1996; 72: 70-1.
73. Hongcharu W, Taylor CR, Chang Y, et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000; 115: 183-92.
74. Pollock B, Turner D, Stringer MR, et al. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action. Br J Dermatol 2004; 151: 616-22.
75. Seyqer MM, van den Hoogen FH, de Boo T, et al. Reliability of two methods to assess morphea: skin scoring and the use of a durometer. J Am Acad Dermatol 1997; 37: 793-6.
76. Rook AH, Freundlich B, Jegasothy BV, et al. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial. Arch Dermatol 1992; 128: 337-46.
77. Hillemanns P, Untch M, Prove F, et al. Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obstet Gynecol 1999; 93: 71-4.
78. Stender IM, Wulf HC. Photodynamic therapy with 5-aminolevulinic acid in the treatment of actinic cheilitis. Br J Dermatol 1996; 135: 454-6.
79. Dierickx CC, Goldenhersh M, Dwyer P, et al. Photodynamic therapy for nevus sebaceus with topical delta-aminolevulinic acid. Arch Dermatol 1999; 135: 637-40.
80. Karrer S, Szeimies RM, Abels C, et al. Epidermodysplasia verruciformis treated using topical 5-aminolaevulinic acia photodynamic therapy. Br J Dermatol 1999; 140: 935-8.